Immunotherapy through the Lens of Non-Small Cell Lung Cancer
Cancers · 30.05.2023 · 15 (11) · 2996
DOI: 10.3390/cancers15112996 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.05.2023. Verfasst von Robyn Stanley und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mid-Western Cancer foundation, All-Ireland Cancer Research Institute, Irish Cancer Society.
Abstract (Originalsprache)
Immunotherapy has revolutionised anti-cancer treatment in solid organ malignancies. Specifically, the discovery of CTLA-4 followed by PD-1 in the early 2000s led to the practice-changing clinical development of immune checkpoint inhibitors (ICI). Patients with lung cancer, including both small cell (SCLC) and non-small cell lung cancer (NSCLC), benefit from the most commonly used form of immunotherapy in immune checkpoint inhibitors (ICI), resulting in increased survival and quality of life. In NSCLC, the benefit of ICIs has now extended from advanced NSCLC to earlier stages of disease, resulting in durable benefits and the even the emergence of the word ‘cure’ in long term responders. However, not all patients respond to immunotherapy, and few patients achieve long-term survival. Patients may also develop immune-related toxicity, a small percentage of which is associated with significant mortality and morbidity. This review article highlights the various types of immunotherapeutic strategies, their modes of action, and the practice-changing clinical trials that have led to the widespread use of immunotherapy, with a focus on ICIs in NSCLC and the current challenges associated with advancing the field of immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland.
- Beaumont Hospital, D09 V2N0 Dublin, Ireland.
- Department of Medicine, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
- Sidney Kimmel Comprehensive Cancer Centre, Johns Hopkins University, Baltimore, MD 21218, USA.
ORCID-Profile: Catríona M Dowling
Förderung
- Mid-Western Cancer foundation
- All-Ireland Cancer Research Institute
- Irish Cancer Society
- Higher Education Authority
- Department of Further and Higher Education, Research, Innovation and Science
- Shared Island Fund
- Irish Cancer Society Clinician Research Leader Award
Zitieren
APA
Stanley, R., Flanagan, S., Reilly, D. O., Kearney, E., Naidoo, J., & Dowling, C. M. (2023). Immunotherapy through the Lens of Non-Small Cell Lung Cancer. Cancers, 15(11), 2996. https://doi.org/10.3390/cancers15112996
Vancouver
Stanley R, Flanagan S, Reilly DO, Kearney E, Naidoo J, Dowling CM. Immunotherapy through the Lens of Non-Small Cell Lung Cancer. Cancers. 2023;15(11):2996. doi:10.3390/cancers15112996
BibTeX
@article{Stanley2023,
author = {Stanley, Robyn and Flanagan, Saoirse and Reilly, David O' and Kearney, Ella and Naidoo, Jarushka and Dowling, Catríona M},
title = {Immunotherapy through the Lens of Non-Small Cell Lung Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {11},
pages = {2996},
doi = {10.3390/cancers15112996}
}
EUVIMED